US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neo-Concept International Group Holdings Limited

13.55

-1.3000-8.75%

Post-market: 13.550.00000.00%19:30 EDT

Volume:994.56K

Turnover:13.95M

Market Cap:32.04M

PE:161.53

High:14.60

Open:14.48

Low:12.71

Close:14.85

52wk High:110.48

52wk Low:2.56

Shares:2.36M

Float Shares:2.36M

Volume Ratio:0.87

T/O Rate:42.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0839

EPS(LYR):0.0822

ROE:0.58%

ROA:0.90%

PB:4.44

PE(LYR):164.79

Loading ...

Overview Company News Filings

Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

Neo-Concept International Group Holdings announces extraordinary shareholder meeting

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:41 AM

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial

Qing Hua Holding appoints Wong Chun Kwok as independent non-executive director

Neo-Concept International files Form 3 for director Wong Chun Kwok

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas

Shell first quarter 2026 update note

Neo-Concept director and chairman Mark Singer resigns from board

Neo-Concept International Grp Hldngs Ltd trading resumes

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:03 PM

Neo-Concept International Group Holdings files Form 3 initial beneficial ownership statement; CFO Patrick Kwok Fai Lau reports no securities owned

Neo-Concept International Group Holdings; Director Mark Gary Singer files initial beneficial ownership statement`

Press Release: Precigen Reports Full Year 2025 Financial Results and Business Updates

Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%

Press Release: Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

Neo-Concept CEO Eva Yuk Yin Siu files Form 3 initial beneficial ownership statement

Neo-Concept International Group Holdings Ltd. Director Billy Chun Fai Tang Files Initial Beneficial Ownership Statement

Neo-Concept International Grp Hldngs Ltd trading resumes

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/NCI/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NCI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NCI\",,,,,undefined,":{"symbol":"NCI","market":"US","secType":"STK","nameCN":"Neo-Concept International Group Holdings Limited","latestPrice":13.55,"timestamp":1787688000000,"preClose":14.85,"halted":0,"volume":994557,"hourTrading":{"tag":"盘后","latestPrice":13.55,"preClose":13.55,"latestTime":"19:30 EDT","volume":51,"amount":690.85,"timestamp":1787700601269,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.08754208754208748,"floatShares":2361000,"shares":2364282,"eps":0.083884,"marketStatus":"Not Yet Opened","change":-1.3,"latestTime":"08-25 16:00:00 EDT","open":14.48,"high":14.6,"low":12.71,"amount":13949175.613690501,"amplitude":0.127273,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.083884,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1713844800000,"exchange":"NASDAQ","adjPreClose":14.85,"preHourTrading":{"tag":"盘前","latestPrice":15.1026,"preClose":14.85,"latestTime":"07:05 EDT","volume":182,"amount":2700.751326,"timestamp":1787655917394,"change":0.2526,"changeRate":0.01701,"amplitude":0.127946},"postHourTrading":{"tag":"盘后","latestPrice":13.55,"preClose":13.55,"latestTime":"19:30 EDT","volume":51,"amount":690.85,"timestamp":1787700601269,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.868719},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NCI\",,,,,undefined,":{"symbol":"NCI","floatShares":2361000,"roa":"0.90%","roe":"0.58%","lyrEps":0.082224,"volumeRatio":0.868719,"shares":2364282,"dividePrice":0,"high":14.6,"amplitude":0.127273,"preClose":14.85,"low":12.71,"week52Low":2.56,"pbRate":"4.44","psRate":"1.83","week52High":110.48,"institutionHeld":0.7857,"latestPrice":13.55,"eps":0.083884,"divideRate":0,"volume":994557,"delay":0,"ttmEps":0.083884,"open":14.48,"prevYearClose":9.04,"prevWeekClose":12.99,"prevMonthClose":12.39,"prevQuarterClose":11.47,"fiveDayClose":12.5,"twentyDayClose":11.96,"sixtyDayClose":10.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NCI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-19","symbol":"NCI","defaultRemindTime":1779197400000,"type":"split","dateTimestamp":1779163200000,"forFactor":8,"toFactor":1,"ratio":8},{"market":"US","date":"2025-06-16","symbol":"NCI","defaultRemindTime":1750080600000,"type":"split","dateTimestamp":1750046400000,"forFactor":5,"toFactor":1,"ratio":5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NCI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NCI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NCI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NCI","date":"2026-08-24","current":161.532593,"percent":1,"low":-615.963293,"twenty":6.114287,"median":10.125486,"eighty":34.44452,"high":725.620028,"avg":91.624058,"sd":206.310568,"marketCap":30712023},"quantilePoints":[{"date":"2024-04-26","current":-152.934443,"twenty":-421.533502,"median":-222.424043,"eighty":-152.416021,"marketCap":47955200},{"date":"2024-05-03","current":-75.704037,"twenty":-208.526123,"median":-121.807344,"eighty":-81.702314,"marketCap":23774400},{"date":"2024-05-10","current":-74.39805,"twenty":-152.15681,"median":-81.565326,"eighty":-71.297323,"marketCap":23368000},{"date":"2024-05-17","current":36.631419,"twenty":-133.739762,"median":-74.39805,"eighty":-23.514082,"marketCap":20726400},{"date":"2024-05-24","current":30.19238,"twenty":-105.051475,"median":-71.169081,"eighty":36.421773,"marketCap":17068800},{"date":"2024-05-31","current":25.951993,"twenty":-89.228644,"median":-65.79629,"eighty":35.854613,"marketCap":14650720},{"date":"2024-06-07","current":26.211896,"twenty":-81.702314,"median":25.015338,"eighty":34.642796,"marketCap":14813280},{"date":"2024-06-14","current":29.519581,"twenty":-78.809845,"median":25.103888,"eighty":32.998302,"marketCap":16682720},{"date":"2024-06-21","current":25.962557,"twenty":-75.44284,"median":25.889128,"eighty":31.491027,"marketCap":14685264},{"date":"2024-06-28","current":22.645555,"twenty":-74.134092,"median":25.192438,"eighty":30.05782,"marketCap":12803632},{"date":"2024-07-05","current":22.365126,"twenty":-73.07826,"median":25.015338,"eighty":29.519581,"marketCap":12639040},{"date":"2024-07-12","current":23.313894,"twenty":-71.810291,"median":24.273321,"eighty":28.980357,"marketCap":13183616},{"date":"2024-07-19","current":21.771249,"twenty":-70.527871,"median":24.005484,"eighty":28.783514,"marketCap":12305792},{"date":"2024-07-26","current":19.871565,"twenty":-67.981499,"median":23.548157,"eighty":28.579978,"marketCap":11236980},{"date":"2024-08-02","current":17.380948,"twenty":-63.611082,"median":23.313894,"eighty":28.402846,"marketCap":9828784},{"date":"2024-08-09","current":14.824233,"twenty":14.824233,"median":22.666232,"eighty":28.339976,"marketCap":8393176},{"date":"2024-08-16","current":14.891311,"twenty":14.824233,"median":22.428658,"eighty":26.393551,"marketCap":8432800},{"date":"2024-08-23","current":16.505019,"twenty":14.824233,"median":21.843651,"eighty":26.38192,"marketCap":9347200},{"date":"2024-08-30","current":15.221442,"twenty":14.891311,"median":21.615595,"eighty":26.235018,"marketCap":8617712},{"date":"2024-09-06","current":14.786956,"twenty":14.816778,"median":21.03365,"eighty":26.21652,"marketCap":8375904},{"date":"2024-09-13","current":18.291286,"twenty":14.783803,"median":19.997266,"eighty":26.012425,"marketCap":10355072},{"date":"2024-09-20","current":25.287335,"twenty":14.816778,"median":19.871565,"eighty":26.012425,"marketCap":14325600},{"date":"2024-09-27","current":18.961375,"twenty":14.877895,"median":19.084343,"eighty":25.954106,"marketCap":10769600},{"date":"2024-10-04","current":21.913118,"twenty":15.042266,"median":20.067523,"eighty":26.126798,"marketCap":12454128},{"date":"2024-10-11","current":22.176748,"twenty":15.165199,"median":20.049509,"eighty":25.99115,"marketCap":12598400},{"date":"2024-10-18","current":32.898839,"twenty":15.206634,"median":20.803771,"eighty":26.126798,"marketCap":18694400},{"date":"2024-10-25","current":23.358148,"twenty":15.219487,"median":21.352319,"eighty":26.21652,"marketCap":13270992},{"date":"2024-11-01","current":27.487373,"twenty":15.232907,"median":21.771249,"eighty":26.583872,"marketCap":15603728},{"date":"2024-11-08","current":26.826792,"twenty":15.38624,"median":21.882165,"eighty":26.827702,"marketCap":15231872},{"date":"2024-11-15","current":22.217928,"twenty":15.464941,"median":22.207911,"eighty":26.517352,"marketCap":12598400},{"date":"2024-11-22","current":19.532206,"twenty":15.526206,"median":22.192329,"eighty":26.402839,"marketCap":11076432},{"date":"2024-11-29","current":19.712189,"twenty":15.580772,"median":21.882165,"eighty":26.386572,"marketCap":11184128},{"date":"2024-12-06","current":18.691913,"twenty":15.639248,"median":21.771249,"eighty":26.293779,"marketCap":10607040},{"date":"2024-12-13","current":18.611126,"twenty":15.691094,"median":21.352319,"eighty":26.221145,"marketCap":10566400},{"date":"2024-12-20","current":7.102414,"twenty":15.639248,"median":20.803771,"eighty":26.151136,"marketCap":10058400},{"date":"2024-12-27","current":7.471029,"twenty":15.444399,"median":20.742686,"eighty":26.108587,"marketCap":10592816},{"date":"2025-01-03","current":10.196837,"twenty":15.213623,"median":20.067523,"eighty":26.07693,"marketCap":14427200},{"date":"2025-01-10","current":10.034934,"twenty":14.891311,"median":20.043836,"eighty":25.962557,"marketCap":14183360},{"date":"2025-01-17","current":9.907617,"twenty":14.749465,"median":19.895277,"eighty":25.951993,"marketCap":14008608},{"date":"2025-01-24","current":9.563114,"twenty":13.631492,"median":19.697706,"eighty":25.85141,"marketCap":13512800},{"date":"2025-01-31","current":8.48834,"twenty":10.018271,"median":19.532206,"eighty":25.746589,"marketCap":11988800},{"date":"2025-02-07","current":7.730432,"twenty":9.882149,"median":19.361654,"eighty":25.46422,"marketCap":10919968},{"date":"2025-02-14","current":7.130829,"twenty":9.483748,"median":19.090069,"eighty":25.309589,"marketCap":10081768},{"date":"2025-02-21","current":7.314786,"twenty":8.865676,"median":18.969464,"eighty":25.26403,"marketCap":10361168},{"date":"2025-02-28","current":5.889209,"twenty":8.594149,"median":18.858804,"eighty":25.21486,"marketCap":8333232},{"date":"2025-03-07","current":6.028973,"twenty":8.100004,"median":18.691913,"eighty":25.173677,"marketCap":8536432},{"date":"2025-03-14","current":5.598897,"twenty":7.846255,"median":18.496802,"eighty":25.10156,"marketCap":7926832},{"date":"2025-03-21","current":5.968988,"twenty":7.540872,"median":18.291286,"eighty":25.033931,"marketCap":8451088},{"date":"2025-03-28","current":7.03753,"twenty":7.389256,"median":18.105135,"eighty":24.856699,"marketCap":9956800},{"date":"2025-04-04","current":6.201809,"twenty":7.119463,"median":17.654152,"eighty":24.701604,"marketCap":8778240},{"date":"2025-04-11","current":6.159082,"twenty":7.009081,"median":17.557752,"eighty":24.560727,"marketCap":8737600},{"date":"2025-04-17","current":6.305413,"twenty":6.892251,"median":17.348506,"eighty":24.472151,"marketCap":8938768},{"date":"2025-04-25","current":5.299322,"twenty":6.518915,"median":16.836333,"eighty":24.40328,"marketCap":7518400},{"date":"2025-05-02","current":4.437465,"twenty":6.31653,"median":16.510738,"eighty":24.325687,"marketCap":6301232},{"date":"2025-05-09","current":5.171449,"twenty":6.285391,"median":16.156269,"eighty":24.224718,"marketCap":7317232},{"date":"2025-05-16","current":6.695699,"twenty":6.181855,"median":15.685852,"eighty":24.063819,"marketCap":6908800},{"date":"2025-05-23","current":7.021962,"twenty":6.235146,"median":15.538955,"eighty":24.008491,"marketCap":7233920},{"date":"2025-05-30","current":8.164705,"twenty":6.285272,"median":15.423857,"eighty":24.005032,"marketCap":8397532},{"date":"2025-06-06","current":8.847265,"twenty":6.289683,"median":15.216555,"eighty":23.931629,"marketCap":9092468},{"date":"2025-06-13","current":8.179292,"twenty":6.306628,"median":15.080005,"eighty":23.644242,"marketCap":8402196},{"date":"2025-06-20","current":10.670242,"twenty":6.311489,"median":14.824233,"eighty":23.64022,"marketCap":10960400},{"date":"2025-06-27","current":11.716334,"twenty":6.315883,"median":14.760327,"eighty":23.456094,"marketCap":12034985},{"date":"2025-07-03","current":10.216346,"twenty":6.317177,"median":14.71349,"eighty":23.384943,"marketCap":10494000},{"date":"2025-07-11","current":10.261711,"twenty":6.410478,"median":11.716334,"eighty":23.359949,"marketCap":10540640},{"date":"2025-07-18","current":9.808428,"twenty":6.454657,"median":10.875077,"eighty":23.322745,"marketCap":10077038},{"date":"2025-07-25","current":9.671429,"twenty":6.462794,"median":10.624987,"eighty":23.130117,"marketCap":9934320},{"date":"2025-08-01","current":8.89955,"twenty":6.57431,"median":10.442049,"eighty":23.054884,"marketCap":9141440},{"date":"2025-08-08","current":8.26371,"twenty":6.676961,"median":10.261711,"eighty":22.850835,"marketCap":8488480},{"date":"2025-08-15","current":8.020396,"twenty":6.711807,"median":10.206559,"eighty":22.709857,"marketCap":8255280},{"date":"2025-08-22","current":7.944228,"twenty":6.718226,"median":10.054926,"eighty":22.653826,"marketCap":8198379},{"date":"2025-08-29","current":7.484931,"twenty":6.73937,"median":9.97069,"eighty":22.584141,"marketCap":7742240},{"date":"2025-09-05","current":9.159836,"twenty":6.821347,"median":9.934593,"eighty":22.562922,"marketCap":9467920},{"date":"2025-09-12","current":9.23611,"twenty":6.883125,"median":9.907617,"eighty":22.500907,"marketCap":9561200},{"date":"2025-09-19","current":8.862273,"twenty":6.893296,"median":9.771265,"eighty":22.442063,"marketCap":9188080},{"date":"2025-09-26","current":7.431141,"twenty":6.901678,"median":9.711704,"eighty":22.390539,"marketCap":7701314},{"date":"2025-10-03","current":7.413811,"twenty":6.942194,"median":9.659792,"eighty":22.276807,"marketCap":7680994},{"date":"2025-10-10","current":7.489961,"twenty":6.99974,"median":9.578721,"eighty":22.211918,"marketCap":7762274},{"date":"2025-10-17","current":7.128574,"twenty":6.974212,"median":9.51173,"eighty":22.189213,"marketCap":7396512},{"date":"2025-10-24","current":6.854291,"twenty":6.883125,"median":9.462569,"eighty":22.01857,"marketCap":7112031},{"date":"2025-10-31","current":6.186973,"twenty":6.854004,"median":9.33225,"eighty":21.875975,"marketCap":6421148},{"date":"2025-11-07","current":4.741629,"twenty":6.765339,"median":9.223624,"eighty":21.842138,"marketCap":4917461},{"date":"2025-11-14","current":4.19042,"twenty":6.696493,"median":9.126243,"eighty":21.797185,"marketCap":4348499},{"date":"2025-11-21","current":3.92273,"twenty":6.462068,"median":9.081059,"eighty":21.677857,"marketCap":4064018},{"date":"2025-11-28","current":4.258196,"twenty":6.343606,"median":9.054357,"eighty":21.613946,"marketCap":4754901},{"date":"2025-12-05","current":4.259674,"twenty":6.293615,"median":8.88422,"eighty":21.40415,"marketCap":4754901},{"date":"2025-12-12","current":4.514242,"twenty":6.192907,"median":8.860854,"eighty":21.069359,"marketCap":5039382},{"date":"2025-12-19","current":5.42375,"twenty":6.139436,"median":8.843088,"eighty":20.941698,"marketCap":6055386},{"date":"2025-12-26","current":4.946749,"twenty":6.043228,"median":8.826007,"eighty":20.793652,"marketCap":5527064},{"date":"2026-01-02","current":4.114478,"twenty":6.028003,"median":8.79797,"eighty":20.753178,"marketCap":4592340},{"date":"2026-01-09","current":4.520095,"twenty":5.916655,"median":8.737897,"eighty":20.742686,"marketCap":5039382},{"date":"2026-01-16","current":4.304481,"twenty":5.809528,"median":8.606,"eighty":20.122966,"marketCap":4795541},{"date":"2026-01-23","current":4.012602,"twenty":5.729394,"median":8.586921,"eighty":20.078612,"marketCap":4470419},{"date":"2026-01-30","current":3.980203,"twenty":5.598444,"median":8.507076,"eighty":20.055999,"marketCap":4429779},{"date":"2026-02-06","current":4.032698,"twenty":5.480595,"median":8.444427,"eighty":20.045692,"marketCap":4483424},{"date":"2026-02-13","current":37.103077,"twenty":5.392255,"median":8.400514,"eighty":20.055999,"marketCap":41232559},{"date":"2026-02-20","current":76.39379,"twenty":5.417434,"median":8.490691,"eighty":20.746883,"marketCap":84923940},{"date":"2026-02-27","current":94.703469,"twenty":5.466384,"median":8.569807,"eighty":21.300488,"marketCap":105161940},{"date":"2026-03-06","current":178.696051,"twenty":5.550181,"median":8.593838,"eighty":21.842138,"marketCap":198597189},{"date":"2026-03-13","current":194.105286,"twenty":5.592612,"median":8.694472,"eighty":22.211918,"marketCap":215430665},{"date":"2026-03-20","current":93.116553,"twenty":5.596494,"median":8.786233,"eighty":22.500907,"marketCap":103270538},{"date":"2026-03-27","current":101.552611,"twenty":5.597991,"median":8.826007,"eighty":22.732806,"marketCap":112727547},{"date":"2026-04-02","current":14.162453,"twenty":5.599593,"median":8.843088,"eighty":23.069529,"marketCap":15698634},{"date":"2026-04-10","current":9.569677,"twenty":5.624611,"median":8.860854,"eighty":22.949198,"marketCap":10610764},{"date":"2026-04-17","current":11.819712,"twenty":5.682567,"median":8.861563,"eighty":22.755755,"marketCap":13122545},{"date":"2026-04-24","current":15.859195,"twenty":5.722477,"median":8.89955,"eighty":22.670367,"marketCap":17590036},{"date":"2026-05-01","current":17.892026,"twenty":5.737436,"median":9.014768,"eighty":22.614848,"marketCap":19840804},{"date":"2026-05-08","current":495.663738,"twenty":5.761633,"median":9.080539,"eighty":22.949198,"marketCap":20994559},{"date":"2026-05-15","current":460.044786,"twenty":5.79638,"median":9.087647,"eighty":23.363552,"marketCap":19481438},{"date":"2026-05-22","current":502.628102,"twenty":5.81972,"median":9.171983,"eighty":23.860033,"marketCap":21278268},{"date":"2026-05-29","current":564.074823,"twenty":5.840048,"median":9.23611,"eighty":24.081593,"marketCap":23878945},{"date":"2026-06-05","current":586.992376,"twenty":5.866012,"median":9.400306,"eighty":24.480444,"marketCap":24848288},{"date":"2026-06-12","current":612.812013,"twenty":5.894698,"median":9.465693,"eighty":25.052524,"marketCap":25935844},{"date":"2026-06-18","current":611.741591,"twenty":5.916655,"median":9.535197,"eighty":25.248493,"marketCap":25888559},{"date":"2026-06-26","current":634.352071,"twenty":5.968988,"median":9.566396,"eighty":25.826264,"marketCap":26834260},{"date":"2026-07-02","current":649.603074,"twenty":6.007854,"median":9.579667,"eighty":26.106544,"marketCap":27472608},{"date":"2026-07-10","current":677.590929,"twenty":6.022407,"median":9.671404,"eighty":26.384246,"marketCap":28678376},{"date":"2026-07-17","current":673.350552,"twenty":6.027126,"median":9.736964,"eighty":26.896949,"marketCap":28489236},{"date":"2026-07-24","current":654.479152,"twenty":6.028779,"median":9.780279,"eighty":28.438272,"marketCap":27685390},{"date":"2026-07-31","current":674.25316,"twenty":6.029585,"median":9.907617,"eighty":28.862251,"marketCap":28513240},{"date":"2026-08-07","current":640.291977,"twenty":6.031075,"median":9.934593,"eighty":29.606307,"marketCap":27071028},{"date":"2026-08-14","current":672.339857,"twenty":6.066093,"median":9.989759,"eighty":30.873854,"marketCap":28418669},{"date":"2026-08-21","current":693.780353,"twenty":6.107955,"median":10.090206,"eighty":33.972934,"marketCap":29340739},{"date":"2026-08-24","current":725.620028,"twenty":6.114287,"median":10.125486,"eighty":34.44452,"marketCap":30712023}],"updateTime":1787707169155},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NCI\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629836527","title":"Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™","url":"https://stock-news.laohu8.com/highlight/detail?id=2629836527","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629836527?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:30","pubTimestamp":1776943800,"startTime":"0","endTime":"0","summary":"HOUSTON, April  23, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/23/3279782/0/en/Plus-Therapeutics-Initiates-Manufacturing-Activities-with-SpectronRx-Under-a-Master-Services-Agreement-to-Support-GMP-Pivotal-Trial-Readiness-for-REYOBIQ.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4139","BK4143","CDMO","CNS","BK4202","LU2125909759.SGD","LU0728928796.USD","LU2125909916.SGD","LU2211815571.USD","LU0154245673.USD","LU1923622291.USD","NCI","LENZ","BK4135","MSA","LU0757428866.USD","LU0154245756.USD","LU1815336091.USD","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627821228","title":"Neo-Concept International Group Holdings announces extraordinary shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2627821228","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627821228?lang=en_us&edition=fundamental","pubTime":"2026-04-16 23:51","pubTimestamp":1776354714,"startTime":"0","endTime":"0","summary":"Neo-Concept International Group Holdings schedules extraordinary general meeting in Hong Kong on May 8, 2026.Shareholders will vote on a share consolidation covering Class A ordinary shares and Class B ordinary shares.Proposal sets a reverse split ratio within a range of 3-to-1 up to 400-to-1, with final ratio to be set by board by an effective date no later than June 30, 2026.Plan would eliminate fractional consolidated shares, with fractions rounded up to whole shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neo-Concept International Group Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDLfblcb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","NCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627728061","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:41 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2627728061","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627728061?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:41","pubTimestamp":1776260471,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:41 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nAQN2LUO5P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","NCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627931287","title":"PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627931287","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627931287?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:45","pubTimestamp":1776257100,"startTime":"0","endTime":"0","summary":"78% Objective Response Rate (ORR) with PDS01ADC; Parallel trial without PDS01ADC had 35% ORR 2-year survival rate of >80%; Parallel trial without PDS01ADC resulted in 2-year survival rate of ~35% Tria","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/15/3274455/37149/en/PDS-Biotech-Announces-Publication-of-Positive-PDS01ADC-Interim-Phase-2-Clinical-Trial-Data-from-Stage-1-of-NCI-led-Metastatic-Colorectal-Cancer-mCRC-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","LU0572939691.SGD","BK4092","ORR","ADC","BK4585","PFS","SSI","BK1584","BK4113","BK4080","BK4588","LU0264606111.USD","BK4195","BK1550","MSS","PDS","BK4202","NCI","BK4581","XBI","01336","LU0572940350.SGD","BK1184","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627284506","title":"Qing Hua Holding appoints Wong Chun Kwok as independent non-executive director","url":"https://stock-news.laohu8.com/highlight/detail?id=2627284506","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627284506?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:23","pubTimestamp":1776255792,"startTime":"0","endTime":"0","summary":"Qing Hua Holding Group reshaped board composition effective April 15, 2026, with independent non-executive director Ip Wai Hung stepping down.Wong Chun Kwok joined as independent non-executive director, taking over chair of Nomination Committee.Wong brings more than 20 years of accounting and finance experience, including former CFO role at Huisen Shares Group.He has held board roles at Datasea Inc. since 2018, with a recent independent director appointment at Neo-Concept International Group Holdings in March 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qing Hua Holding Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL5J26S8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","BK1128","DTSS","BK4097","BK1605","08082","NCI","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627770431","title":"Neo-Concept International files Form 3 for director Wong Chun Kwok","url":"https://stock-news.laohu8.com/highlight/detail?id=2627770431","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627770431?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:24","pubTimestamp":1776075853,"startTime":"0","endTime":"0","summary":"Neo-Concept International Group filed an initial Form 3 disclosing director Wong Chun Kwok as a reporting insider, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neo-Concept International Group Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL9p2q1X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCI","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625949165","title":"Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2625949165","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625949165?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:30","pubTimestamp":1775647800,"startTime":"0","endTime":"0","summary":"HOUSTON, April  08, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq:PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/08/3270005/0/en/Plus-Therapeutics-Granted-U-S-FDA-Orphan-Drug-Designation-to-REYOBIQ-in-Pediatric-Malignant-Gliomas.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","CSF","IE0009354923.USD","IND","BK4135","ODD","BK4539","BK4202","NCI","CNS","BK4585","LENZ","BK4007","BK4139","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625199011","title":"Shell first quarter 2026 update note","url":"https://stock-news.laohu8.com/highlight/detail?id=2625199011","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625199011?lang=en_us&edition=fundamental","pubTime":"2026-04-08 14:00","pubTimestamp":1775628000,"startTime":"0","endTime":"0","summary":"The following is an update to the first quarter 2026 outlook and gives an overview of our current expectations for the first quarter. Outlooks presented may vary from the actual first quarter 2026 res","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/08/3269813/0/en/Shell-first-quarter-2026-update-note.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MT","BK4202","BK4561","NCI","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624947645","title":"Neo-Concept director and chairman Mark Singer resigns from board","url":"https://stock-news.laohu8.com/highlight/detail?id=2624947645","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624947645?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:20","pubTimestamp":1775038851,"startTime":"0","endTime":"0","summary":"Neo-Concept International Group said Mark Gary Singer resigned as director and board chairman effective March 31, 2026.Singer’s resignation was not tied to any disagreement over company operations, policies, or practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neo-Concept International Group Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDLtnfW6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","NCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624805531","title":"Neo-Concept International Grp Hldngs Ltd trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2624805531","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624805531?lang=en_us&edition=fundamental","pubTime":"2026-04-01 01:11","pubTimestamp":1774977118,"startTime":"0","endTime":"0","summary":"13:05 EDT Neo-Concept (NCI) International Grp Hldngs Ltd trading resumes Published first on TheFly – the ultimate source for real-time, market-movi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neo-concept-international-grp-hldngs-ltd-trading-resumes-thefly-news-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neo-concept-international-grp-hldngs-ltd-trading-resumes-thefly-news-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NCI","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624535085","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 12:03 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2624535085","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624535085?lang=en_us&edition=fundamental","pubTime":"2026-04-01 00:03","pubTimestamp":1774973027,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 12:03 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nAQN2LSMOV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","NCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622828453","title":"Neo-Concept International Group Holdings files Form 3 initial beneficial ownership statement; CFO Patrick Kwok Fai Lau reports no securities owned","url":"https://stock-news.laohu8.com/highlight/detail?id=2622828453","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622828453?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:51","pubTimestamp":1774608706,"startTime":"0","endTime":"0","summary":"Neo-Concept International Group Holdings files Form 3 initial beneficial ownership statement; CFO Patrick Kwok Fai Lau reports no securities owned. Neo-Concept said Patrick Kwok Fai Lau filed an initial Form 3 as chief financial officer, dated 03/18/2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neo-Concept International Group Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDLbJB4Mg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCI","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622285108","title":"Neo-Concept International Group Holdings; Director Mark Gary Singer files initial beneficial ownership statement`","url":"https://stock-news.laohu8.com/highlight/detail?id=2622285108","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622285108?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:44","pubTimestamp":1774608244,"startTime":"0","endTime":"0","summary":"Neo-Concept said director Mark Gary Singer filed an initial Form 3 statement dated 03/18/2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neo-Concept International Group Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL1y1kDX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCI","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622046100","title":"Press Release: Precigen Reports Full Year 2025 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2622046100","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622046100?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:05","pubTimestamp":1774469100,"startTime":"0","endTime":"0","summary":"-- Precigen transitioned to a commercial stage company with the US approval. FDA-approved treatment for adults with RRP, in August 2025. -- PAPZIMEOS generated $3.4 million in net product revenue in the fourth. quarter of 2025, reflecting the first partial quarter of US commercial. sales as payer policies came into effect; the US launch continues to. build strong momentum, with a significant increase in demand in the first. J-code, J3404, to PAPZIMEOS, effective April 1, 2026, streamlining the. -- Marketing Authorization Application for PAPZIMEOS for the treatment of. physicians in the field of RRP recommended PAPZIMEOS as the new standard. \"Commercialization of PAPZIMEOS continues to move rapidly, with growing physician adoption and patient uptake since approval in August. Sinc","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4604","BK4202","BK4022","BK4555","BK4232","BK4588","BK4585","BK4139","03160","LABU","BK4099","TM","PGEN","NCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620228692","title":"Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228692","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228692?lang=en_us&edition=fundamental","pubTime":"2026-03-19 19:30","pubTimestamp":1773919800,"startTime":"0","endTime":"0","summary":"Health economics analysis highlights the economic burden of late-stage leptomeningeal metastases (LM) and the potential value of earlier diagnosis using CNSide as it enters U.S. commercializationHOUST","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/19/3258891/0/en/Plus-Therapeutics-to-Present-New-Analysis-at-ISPOR-Showing-CNSide-May-Reduce-Leptomeningeal-Metastases-Healthcare-Costs-by-40.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CSF","BK4007","HCSG","BK4581","BK4139","LABU","CNS","XLV","BK4202","BK4135","BK4588","LU0029874061.USD","BK4137","NCI","BK4585","BK4539","XBI","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620429837","title":"Press Release: Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620429837","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620429837?lang=en_us&edition=fundamental","pubTime":"2026-03-19 05:31","pubTimestamp":1773869460,"startTime":"0","endTime":"0","summary":"Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses. Research published in Nature Medicine highlighted promising results of multi-antigen targeted T cells in pancreatic cancer. Strengthened manufacturing capabilities through collaboration with Cellipont Bioservices and expanded Board of Directors with appointment of Kathryn Penkus Corzo. HOUSTON, March 18, 2026  -- Marker Therapeutics, Inc. , a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematological malignancies and solid tumors, today announced corporate updates and financial results for the year ended December 31, 2025.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRKR","IE00B1G9WX41.USD","MAR","BK4585","LU2404859741.USD","NCI","ASH","LU2463526074.USD","IE00BD0PCF45.HKD","IE00B95QR487.USD","LU0690374961.EUR","GB00B4LPDJ14.GBP","BK4202","BK4007","BK4588","IE00B0T0GQ85.USD","LU0690374615.EUR","LU2404859667.USD","GB00B4QBRK32.GBP","BK4139","BK4109","BK4539","LENZ","BK4142","LU1718418525.SGD","IE00B45NX917.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620886252","title":"Neo-Concept CEO Eva Yuk Yin Siu files Form 3 initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620886252","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620886252?lang=en_us&edition=fundamental","pubTime":"2026-03-18 22:20","pubTimestamp":1773843634,"startTime":"0","endTime":"0","summary":"Neo-Concept said Eva Yuk Yin Siu filed an initial statement of beneficial ownership. Siu is the company’s chief executive officer and a director. The filing also lists Siu as a 10% owner. Siu reported indirect beneficial ownership of 2.38 million Class A ordinary shares. Siu also reported indirect beneficial ownership of 0.53 million Class B ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neo-Concept International Group Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL4w7G6g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","NCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620254030","title":"Neo-Concept International Group Holdings Ltd. Director Billy Chun Fai Tang Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620254030","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620254030?lang=en_us&edition=fundamental","pubTime":"2026-03-18 22:19","pubTimestamp":1773843568,"startTime":"0","endTime":"0","summary":"Neo-Concept filed an initial statement of beneficial ownership on March 18, 2026. Billy Chun Fai Tang was listed as a director. The filing stated that no securities were beneficially owned by Tang.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neo-Concept International Group Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLM2xST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCI","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619646962","title":"Neo-Concept International Grp Hldngs Ltd trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2619646962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619646962?lang=en_us&edition=fundamental","pubTime":"2026-03-16 21:50","pubTimestamp":1773669009,"startTime":"0","endTime":"0","summary":"09:47 EDT Neo-Concept (NCI) International Grp Hldngs Ltd trading resumes Published first on TheFly – the ultimate source for real-time, market-movi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neo-concept-international-grp-hldngs-ltd-trading-resumes-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neo-concept-international-grp-hldngs-ltd-trading-resumes-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4202","NCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619667684","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:42 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2619667684","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619667684?lang=en_us&edition=fundamental","pubTime":"2026-03-16 21:42","pubTimestamp":1773668572,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:42 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nAQN2LQFNU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCI","BK4202"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":67,"code":"91000000","status":"200"}]}}